ISS National Lab logo

ISS National Lab

North America, Florida, United States, Melbourne

Description

ISS National Lab is a space research company that enables commercial, academic, and government in space research development access.

Investor Profile

ISS National Lab has made 4 investments, with 0 in the past 12 months and 50% as lead.

Stage Focus

  • Grant (75%)
  • Pre Seed (25%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Pharmaceutical
  • Biotechnology
  • Therapeutics
  • Medical
  • Medical Device
  • Aerospace
  • Drones
  • Machinery Manufacturing
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does ISS National Lab frequently co-invest with?

Google Cloud
North America, California, United States, San Francisco
Co-Investments: 1
CTNext
North America, Connecticut, United States, Rocky Hill
Co-Investments: 1
The Boeing Company
North America, Virginia, United States, Arlington
Co-Investments: 1
Connecticut Innovations
North America, Connecticut, United States, Rocky Hill
Co-Investments: 1

What are some of recent deals done by ISS National Lab?

FluxWorks

College Station, Texas, United States

FluxWorks offers superior powertrain solutions that propel human invention.

AerospaceDronesMachinery Manufacturing
GrantFeb 12, 2024
Symphony Biosciences

Los Angeles, California, United States

Symphony Biosciences empowers the immune system to fight cancer.

BiotechnologyHealth CareLife ScienceTherapeutics
GrantFeb 12, 2024
Encapsulate

Farmington, Connecticut, United States

Automated tumor-on-a-chip systems that screen patients' clinical response profile and determine effective personalized treatment regimens.

Health CareMedicalMedical DevicePharmaceutical
Pre SeedAug 19, 2020
Amount Raised: $953,000
Kernal Biologics

Cambridge, Massachusetts, United States

Kernalbio creates mRNA therapies that instruct specific cells on how to make their own medicine.

BiotechnologyPharmaceuticalTherapeutics
GrantOct 18, 2018